Si hablamos de la obesidad, consigue reducir el peso corporal en un 22 % frente al 16 % del medicamento comercializado por Novo Nordisk
The company brought in revenue of $608 million in Q1, up 4% year-over-year
Vomiting: While less common than nausea, vomiting can also occur with GLP-1 receptor agonists
Managing side effects to prevent early discontinuation This principle extends beyond side effects to regular monitoring and dose optimization, integration with lifestyle modifications, and planning for long-term maintenance rather than just weight loss
Stay on track with Pivot Get free access to Pivot, the GLP-1 tracking app built to help you log your doses, track side effects, monitor habits, and see your progress clearly, all in one place
Switching from a 29-gauge needle to a 31 or 32-gauge needle reduces tissue displacement and capillary damage